CTIS.eu › Cities › Spain › Esplugues De Llobregat
Esplugues De Llobregat
Spain
317 total trials
151 recruiting
2023-509809-76-00
5
2023-02-28
Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)
2024-514173-22-00
5
2023-02-28
Cystic Fibrosis
2024-511852-42-00
5
2023-01-19
Spinal Muscular Atrophy
2023-510351-31-00
7
2023-01-06
Duchenne muscular dystrophy
2024-518675-55-00
4
2022-12-02
Girls with advanced puberty and accelerated bone maturation. Polycysti
2024-515637-14-00
5
2022-11-08
Cystic Fibrosis
2023-509229-31-00
5
2022-09-28
Metabolic Disorders - Phenylketonuria
2023-506927-27-00
5
2022-08-29
Children with short stature either born small for gestational age or w
2024-512289-33-00
5
2022-08-24
Mucopolysaccharidosis type II
2023-507634-24-00
5
2022-05-20
Improper function of certain messenger materials in the body that cont
2023-506761-65-00
10
2022-04-08
Spinal Muscular Atrophy (SMA)
2023-506357-38-00
9
2022-02-17
Neurofibromatosis Type 1 (NF1) Related Plexiform Neurofibromas (PN)
2023-506516-40-00
5
2022-02-11
Relapsing-Remitting Multiple Sclerosis
2023-504884-17-00
5
2022-02-04
Proteinuria
2024-511492-15-00
5
2021-12-09
Duchenne Muscular Dystrophy
2023-505637-27-00
5
2021-07-12
Spinal Muscular Atrophy
2023-508530-34-00
4
2021-04-19
PIK3CA-Related Overgrowth Spectrum (PROS)
2023-507418-28-00
4
2021-03-15
Solid tumors
2023-505964-13-00
5
2021-03-09
Hemophilia A
2023-507184-19-00
5
2021-02-22
Juvenile Psoriatic Arthritis
Enthesitis Related Arthritis
2022-501012-34-00
5
2020-02-27
Pulmonary Arterial Hypertension
2023-505088-35-00
9
2019-12-12
Pediatric Solid tumors and primary central nervous system (CNS) tumors
2024-513774-21-00
4
2019-09-13
CEREBRAL X-LINKED ADRENOLEUKODYSTROPHY (CALD)
2023-510427-29-00
4
2019-09-04
Thymidine kinase 2 deficiency
Showing 217–240 of 317 trials